Axsome Therapeutics (AXSM) News Today $118.63 +2.01 (+1.72%) Closing price 09/18/2025 04:00 PM EasternExtended Trading$119.00 +0.37 (+0.31%) As of 09/18/2025 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why Is Axsome Therapeutics Up Today?Toggle Visibility of Why Is Axsome Therapeutics Up Today?Axsome Therapeutics, Inc. (NASDAQ:AXSM) shares moved today as investors weighed a mix of bullish technical signals and clinical exposure against insider sales and a weaker earnings outlook. Positive Sentiment: Technical momentum: AXSM is among stocks generating improved relative strength, indicating it has outperformed peers in recent sessions. Stocks Generating Improved Relative Strength: Axsome Therapeutics Positive Sentiment: Pipeline visibility: Presented six poster sessions at Psych Congress 2025 covering major depressive disorder, Alzheimer’s agitation, narcolepsy and sleep apnea, underscoring ongoing clinical progress. Axsome Therapeutics Highlights Data Across Its Leading Neuroscience Pipeline at Psych Congress 2025 Neutral Sentiment: Investor outreach: Executives spoke at TD Cowen’s 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit, maintaining visibility with analysts. Axsome Therapeutics, Inc. Presents at TD Cowen Summit Negative Sentiment: Insider selling: COO Mark Jacobson sold 45,783 shares at an average of $114.48, divesting $5.24 million. Insider Selling: Axsome Therapeutics COO Sells Shares Negative Sentiment: Insider selling: CEO Herriot Tabuteau has offloaded over 62,000 shares in recent weeks, signaling substantial insider divestment. Axsome Therapeutics CEO Sells Shares Negative Sentiment: Analyst downgrade: Cantor Fitzgerald cut its FY2026 EPS estimate for AXSM to ($2.54) from ($2.27), reflecting a more challenging outlook for losses. Cantor Fitzgerald Cuts FY2026 EPS Estimates Posted 5h agoAI Generated. May Contain Errors. AXSM Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Stocks Generating Improved Relative Strength: Axsome TherapeuticsSeptember 18 at 10:43 PM | msn.comInsider Selling: Axsome Therapeutics (NASDAQ:AXSM) COO Sells 45,783 Shares of StockSeptember 18 at 8:43 PM | marketbeat.comPallas Capital Advisors LLC Boosts Holdings in Axsome Therapeutics, Inc. $AXSMSeptember 18 at 6:01 AM | marketbeat.comStrs Ohio Makes New Investment in Axsome Therapeutics, Inc. $AXSMSeptember 18 at 3:13 AM | marketbeat.comAxsome Therapeutics, Inc. (AXSM) Presents at TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit TranscriptSeptember 18 at 2:00 AM | seekingalpha.comAxsome Therapeutics (NASDAQ:AXSM) CEO Herriot Tabuteau Sells 15,254 SharesSeptember 17 at 8:22 PM | marketbeat.comAxsome Therapeutics (NASDAQ:AXSM) CEO Herriot Tabuteau Sells 19,719 SharesSeptember 17 at 8:22 PM | marketbeat.comInsider Selling: Axsome Therapeutics (NASDAQ:AXSM) CEO Sells 27,907 Shares of StockSeptember 17 at 8:22 PM | marketbeat.comAxsome Therapeutics Highlights Data Across Its Leading Neuroscience Pipeline at Psych Congress 2025September 17 at 7:00 AM | globenewswire.comAxsome Therapeutics (NASDAQ:AXSM) CEO Herriot Tabuteau Sells 15,254 SharesSeptember 17 at 5:46 AM | insidertrades.comAxsome Therapeutics, Inc. $AXSM Stock Holdings Trimmed by Voya Investment Management LLCSeptember 17 at 3:26 AM | marketbeat.comAxsome Therapeutics, Inc. $AXSM Shares Purchased by Intech Investment Management LLCSeptember 17 at 3:10 AM | marketbeat.comRhumbline Advisers Purchases 3,515 Shares of Axsome Therapeutics, Inc. $AXSMSeptember 15, 2025 | marketbeat.comMcAdam LLC Acquires New Position in Axsome Therapeutics, Inc. $AXSMSeptember 14, 2025 | marketbeat.comAxsome Therapeutics, Inc. $AXSM Position Reduced by Great Lakes Advisors LLCSeptember 14, 2025 | marketbeat.comAQR Capital Management LLC Has $6.81 Million Stock Holdings in Axsome Therapeutics, Inc. $AXSMSeptember 14, 2025 | marketbeat.comAxsome Therapeutics, Inc. $AXSM Shares Sold by Woodline Partners LPSeptember 12, 2025 | marketbeat.comFred Alger Management LLC Takes $860,000 Position in Axsome Therapeutics, Inc. $AXSMSeptember 12, 2025 | marketbeat.comAxsome Therapeutics (NASDAQ:AXSM) Director Purchases $200,466.00 in StockSeptember 11, 2025 | marketbeat.comTuesday’s Insider Trades: Key Buys and Sells in US Stocks RevealedSeptember 10, 2025 | investing.comAxiom Investors LLC DE Purchases New Shares in Axsome Therapeutics, Inc. $AXSMSeptember 10, 2025 | marketbeat.comInsider Buying: Axsome Therapeutics (NASDAQ:AXSM) Director Buys 1,575 Shares of StockSeptember 10, 2025 | insidertrades.comVident Advisory LLC Makes New $360,000 Investment in Axsome Therapeutics, Inc. $AXSMSeptember 10, 2025 | marketbeat.comScientech Research LLC Purchases Shares of 9,759 Axsome Therapeutics, Inc. $AXSMSeptember 9, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Sells 12,000 Shares of Axsome Therapeutics, Inc. $AXSMSeptember 9, 2025 | marketbeat.comAxsome Therapeutics, Inc. (AXSM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 8, 2025 | seekingalpha.comEventide Asset Management LLC Sells 83,861 Shares of Axsome Therapeutics, Inc. $AXSMSeptember 6, 2025 | marketbeat.comMark Saad Sells 9,127 Shares of Axsome Therapeutics (NASDAQ:AXSM) StockSeptember 6, 2025 | insidertrades.comCormorant Asset Management LP Trims Stock Holdings in Axsome Therapeutics, Inc. $AXSMSeptember 6, 2025 | marketbeat.comAxsome Therapeutics (NASDAQ:AXSM) Raised to Strong-Buy at Wells Fargo & CompanySeptember 6, 2025 | marketbeat.comCanada Pension Plan Investment Board Purchases 40,400 Shares of Axsome Therapeutics, Inc. $AXSMSeptember 6, 2025 | marketbeat.comIeq Capital LLC Purchases New Holdings in Axsome Therapeutics, Inc. $AXSMSeptember 6, 2025 | marketbeat.comBVF Inc. IL Increases Stock Holdings in Axsome Therapeutics, Inc. $AXSMSeptember 5, 2025 | marketbeat.comAxsome Therapeutics (AXSM) Has a New Rating from Wells FargoSeptember 4, 2025 | theglobeandmail.comAxsome Therapeutics (NASDAQ:AXSM) Director Sells $1,665,227.52 in StockSeptember 4, 2025 | marketbeat.comAxsome initiated with Overweight at Wells Fargo on Alzheimer's drug potentialSeptember 3, 2025 | msn.comAxsome Therapeutics assumed with an Overweight at Wells FargoSeptember 3, 2025 | msn.comPDT Partners LLC Purchases 47,004 Shares of Axsome Therapeutics, Inc. $AXSMSeptember 3, 2025 | marketbeat.comPoint72 Europe London LLP Cuts Holdings in Axsome Therapeutics, Inc. $AXSMSeptember 3, 2025 | marketbeat.comRoger Jeffs Sells 13,464 Shares of Axsome Therapeutics (NASDAQ:AXSM) StockSeptember 3, 2025 | insidertrades.comAxsome Therapeutics, Inc. $AXSM Shares Sold by Russell Investments Group Ltd.September 3, 2025 | marketbeat.com5,417 Shares in Axsome Therapeutics, Inc. $AXSM Bought by Landscape Capital Management L.L.C.September 2, 2025 | marketbeat.comH.C. Wainwright Reaffirms Buy on Axsome (AXSM) Following Generic Challenge to PortfolioSeptember 2, 2025 | uk.finance.yahoo.com214,139 Shares in Axsome Therapeutics, Inc. $AXSM Purchased by Driehaus Capital Management LLCSeptember 1, 2025 | marketbeat.comTema Etfs LLC Takes $271,000 Position in Axsome Therapeutics, Inc. $AXSMAugust 31, 2025 | marketbeat.comAxsome Therapeutics, Inc. $AXSM Holdings Trimmed by Tri Locum Partners LPAugust 30, 2025 | marketbeat.comAxsome Therapeutics (NASDAQ:AXSM) Director Roger Jeffs Sells 20,000 SharesAugust 30, 2025 | insidertrades.comFORA Capital LLC Purchases New Shares in Axsome Therapeutics, Inc. $AXSMAugust 30, 2025 | marketbeat.comNorthern Trust Corp Has $47.93 Million Stock Holdings in Axsome Therapeutics, Inc. $AXSMAugust 30, 2025 | marketbeat.comRaymond James Financial Inc. Sells 19,511 Shares of Axsome Therapeutics, Inc. $AXSMAugust 30, 2025 | marketbeat.com Get Axsome Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AXSM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AXSM Media Mentions By Week AXSM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AXSM News Sentiment▼0.910.63▲Average Medical News Sentiment AXSM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AXSM Articles This Week▼2214▲AXSM Articles Average Week Get the Latest News and Ratings for AXSM and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Axsome Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies JAZZ News TEVA News GMAB News SMMT News RDY News ASND News VTRS News QGEN News BBIO News ROIV News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AXSM) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Axsome Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Axsome Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AXSM Stock Alerts